CMN Weekly (10 November 2023) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Nov. 10, 2023
News

#CRISPRMED24

Top picks

Research

Industry

Third quarter 2023 financial results and business updates

Detection

Reviews

Perspectives

Webinars

News from CRISPR Medicine News

  • This Monday, we brought a Startup Spotlight focusing on Ariya Bio. In the ETH Innovation & Entrepreneurship Lab in Z├╝rich (Switzerland), Ariya Bio aims to develop safe and effective gene-editing therapies for genetic diseases. We spoke with two co-founders, Mandy Boontanrart and Jan Nelis, to hear more about Ariya Bio and its unique approach to treating sickle cell disease.

To get more of the CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

News: CMN Weekly (10 November 2023) - Your Weekly CRISPR Medicine News
News: CMN Weekly (10 November 2023) - Your Weekly CRISPR Medicine News
CLINICAL TRIALS
Systemic Lupus Erythematosus SLE, (NCT06255028)
Sponsors:
Century Therapeutics, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Chronic Granulomatous Disease, CGD, (NCT06325709)
Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Sickle Cell Disease, SCD, (NCT06287099)
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine